Literature DB >> 12192088

RNAi functions in cultured mammalian neurons.

Anna M Krichevsky1, Kenneth S Kosik.   

Abstract

In a wide range of organisms, double-stranded RNA triggers posttranscriptional gene silencing or RNA interference (RNAi). Small interfering RNAs, the 21-nt double-stranded RNA intermediates of this natural pathway, have became a powerful tool to knock down specific gene expression in mammalian cell lines and potentially will be useful for the analysis of loss-of-function phenotypes. In mammalian primary neuronal cultures, where genetic manipulations are especially difficult, RNAi might be developed into a highly efficacious tool to study the roles of specific genes in neuron development and functioning. Neurons, however, have been considered the most resistant to RNAi. We report here an application of RNAi to postmitotic primary neuronal cultures. Synthetic siRNA can be readily introduced into neurons and effectively inhibit the expression of endogenous and transfected genes.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2002        PMID: 12192088      PMCID: PMC129370          DOI: 10.1073/pnas.182272699

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals.

Authors:  P D Zamore; T Tuschl; P A Sharp; D P Bartel
Journal:  Cell       Date:  2000-03-31       Impact factor: 41.582

2.  U6 promoter-driven siRNAs with four uridine 3' overhangs efficiently suppress targeted gene expression in mammalian cells.

Authors:  Makoto Miyagishi; Kazunari Taira
Journal:  Nat Biotechnol       Date:  2002-05       Impact factor: 54.908

3.  Suppression of MAP2 in cultured cerebellar macroneurons inhibits minor neurite formation.

Authors:  A Caceres; J Mautino; K S Kosik
Journal:  Neuron       Date:  1992-10       Impact factor: 17.173

4.  Molecular characterization of the dendritic growth cone: regulated mRNA transport and local protein synthesis.

Authors:  P B Crino; J Eberwine
Journal:  Neuron       Date:  1996-12       Impact factor: 17.173

5.  Role for a bidentate ribonuclease in the initiation step of RNA interference.

Authors:  E Bernstein; A A Caudy; S M Hammond; G J Hannon
Journal:  Nature       Date:  2001-01-18       Impact factor: 49.962

6.  Identification of tissue-specific microRNAs from mouse.

Authors:  Mariana Lagos-Quintana; Reinhard Rauhut; Abdullah Yalcin; Jutta Meyer; Winfried Lendeckel; Thomas Tuschl
Journal:  Curr Biol       Date:  2002-04-30       Impact factor: 10.834

7.  Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells.

Authors:  Nan Sook Lee; Taikoh Dohjima; Gerhard Bauer; Haitang Li; Ming-Jie Li; Ali Ehsani; Paul Salvaterra; John Rossi
Journal:  Nat Biotechnol       Date:  2002-05       Impact factor: 54.908

8.  Ingestion of bacterially expressed dsRNAs can produce specific and potent genetic interference in Caenorhabditis elegans.

Authors:  L Timmons; D L Court; A Fire
Journal:  Gene       Date:  2001-01-24       Impact factor: 3.688

9.  RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells.

Authors:  Jenn-Yah Yu; Stacy L DeRuiter; David L Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

10.  Architecture of apical dendrites in the murine neocortex: dual apical dendritic systems.

Authors:  M I Escobar; H Pimienta; V S Caviness; M Jacobson; J E Crandall; K S Kosik
Journal:  Neuroscience       Date:  1986-04       Impact factor: 3.590

View more
  39 in total

1.  Allele-specific silencing of dominant disease genes.

Authors:  Victor M Miller; Haibin Xia; Ginger L Marrs; Cynthia M Gouvion; Gloria Lee; Beverly L Davidson; Henry L Paulson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-02       Impact factor: 11.205

2.  Tolerance for mutations and chemical modifications in a siRNA.

Authors:  Mohammed Amarzguioui; Torgeir Holen; Eshrat Babaie; Hans Prydz
Journal:  Nucleic Acids Res       Date:  2003-01-15       Impact factor: 16.971

Review 3.  RNA interference: from an ancient mechanism to a state of the art therapeutic application?

Authors:  Christoph Arenz; Ute Schepers
Journal:  Naturwissenschaften       Date:  2003-07-23

Review 4.  The search for endogenous siRNAs in the mammalian brain.

Authors:  Neil R Smalheiser
Journal:  Exp Neurol       Date:  2011-10-28       Impact factor: 5.330

5.  Neurite extension in central neurons: a novel role for the receptor tyrosine kinases Ror1 and Ror2.

Authors:  Sabrina Paganoni; Adriana Ferreira
Journal:  J Cell Sci       Date:  2005-01-15       Impact factor: 5.285

Review 6.  RNA interference technologies for understanding and treating neurodegenerative diseases.

Authors:  Bingwei Lu
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

7.  E4F1, a novel estrogen-responsive gene in possible atheroprotection, revealed by microarray analysis.

Authors:  Yasuhiro Nakamura; Katsuhide Igarashi; Takashi Suzuki; Jun Kanno; Tohru Inoue; Chika Tazawa; Masayuki Saruta; Tomoko Ando; Noriko Moriyama; Toru Furukawa; Masao Ono; Takuya Moriya; Kiyoshi Ito; Haruo Saito; Tadashi Ishibashi; Shoki Takahashi; Shogo Yamada; Hironobu Sasano
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

8.  Upregulation of BNIP3 and translocation to mitochondria mediates cyanide-induced apoptosis in cortical cells.

Authors:  K Prabhakaran; L Li; L Zhang; J L Borowitz; G E Isom
Journal:  Neuroscience       Date:  2007-07-29       Impact factor: 3.590

Review 9.  Therapeutic gene silencing in neurological disorders, using interfering RNA.

Authors:  G Scott Ralph; Nicholas D Mazarakis; Mimoun Azzouz
Journal:  J Mol Med (Berl)       Date:  2005-03-10       Impact factor: 4.599

10.  Cytoglobin up-regulated by hydrogen peroxide plays a protective role in oxidative stress.

Authors:  Dan Li; Xiao Qian Chen; Wu-Jian Li; Yu-Hui Yang; Jian-Zhi Wang; Albert Cheung Hoi Yu
Journal:  Neurochem Res       Date:  2007-05-03       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.